BTIG Research initiated coverage on Aravive with a new price target
$ARAV
Biotechnology: Pharmaceutical Preparations
Health Care
BTIG Research initiated coverage of Aravive with a rating of Buy and set a new price target of $26.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/17/2023 | $12.00 | Buy | BTIG Research |
| 6/3/2022 | $15.00 | Buy | ROTH Capital |